Cardiovascular-Kidney-Metabolic Syndrome
Cardiovascular death risk increases with cardiovascular-kidney-metabolic syndrome stage
Higher stages of cardiovascular-kidney-metabolic syndrome may correlate to increased risk of cardiovascular mortality, according to a longitudinal study of U.S. adults.
Therapeutic Strategies for Cardiovascular-Kidney-Metabolic Syndrome: Addressing the Interwoven Triad of Heart Failure, Chronic Kidney Disease, and Diabetes
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc and Eli Lilly and Company.
Top in cardiology: Benefits of vitamin A, weight-loss surgery in those with heart failure
A cross-sectional study revealed that increased vitamin A intake may improve depressive symptoms in patients with heart failure.
Q&A: New initiative to address CKM syndrome, affecting millions in the US
In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.
How PCPs should care for each stage of cardiovascular-kidney-metabolic syndrome
Primary care providers play a critical role in detecting and managing cardiovascular-kidney-metabolic syndrome, according to experts.
VIDEO: Newly defined syndrome is a ‘brilliant concept’ on stages of CVD risk
BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.
Important updates in cardiology from Clyde W. Yancy, MD, MSc
BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.
Top in cardiology: Anger may raise CVD risk; cardiovascular-kidney-metabolic syndrome
A laboratory-based, randomized controlled experimental study revealed that anger can negatively impact vascular endothelial health and function, potentially raising heart disease risk.
Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology.
Removing race from heart disease risk calculator does not impact ASCVD prediction
Modeling data suggest using race stratification in pooled cohort equation risk calculators does not change a person’s risk for developing atherosclerotic CVD, whereas adding social determinants of health did not improve model performance.